pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: grant×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03811002: Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06308653: Psilocybin for Major Depressive Disorder (MDD)

    Sponsor: Usona Institute. Phase: PHASE3. Conditions: Depressive Disorder, Major

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07217353: The Use of a Novel Vaginal Speculum for Endometrial Biopsies

    Sponsor: Rocky Vista University, LLC. Phase: NA. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07366645: Clinical and Cost-Effectiveness of Silver Diamine Fluoride and Silver Fluoride, With or Without Application of LED, in Arresting Incipient Permament Molar Caries

    Sponsor: Cairo University. Phase: NA. Conditions: Incipient Caries

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05523245: Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

    Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: . Conditions: Rectal Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07625072: Mental Rehearsal in Emergency Cricothyroidotomy Training

    Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Difficult Airway, Medical Training, Airway Management, Cricothyroidotomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06060977: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

    Sponsor: Inmagene LLC. Phase: PHASE1. Conditions: Alopecia Areata (AA)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04027777: Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation

    Sponsor: Aktiia SA. Phase: NA. Conditions: Blood Pressure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07299877: Perineural Dexamethasone, Dexmedetomidine, or Their Combination to Reduces Rebound Pain After Supraclavicular Brachial Plexus Block

    Sponsor: Al-Azhar University. Phase: PHASE4. Conditions: Brachial Plexus Blocks

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06138275: Elranatamab in R/R Multiple Myeloma

    Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07487857: Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy

    Sponsor: University of Castilla-La Mancha. Phase: NA. Conditions: Cerebral Palsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07633457: Comparison Between Outcomes of Closure of Idiopathic Macular Hole Using Autologus Tenon Capsule Graft and Internal Limiting Membrane Flap Techniques (Pilot Study)

    Sponsor: Ain Shams University. Phase: NA. Conditions: Macular Hole Surgery, ILM Peeling, Tenon Capsule, ILM Flap, Macular Hole

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05753501: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Hematologic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07372157: Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals

    Sponsor: Marmara University. Phase: NA. Conditions: Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06245057: Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Morbidity;Perinatal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07084857: Association Between Isokinetic Lower Extremity Muscle Strength and Bone Mineral Density in Elderly Women With and Without Osteoporosis

    Sponsor: Cairo University. Phase: . Conditions: Osteoporosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06497101: Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)

    Sponsor: Oslo University Hospital. Phase: NA. Conditions: Anorexia Nervosa

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07556601: Ultra-rapid Blastocyst Vitrification: Pilot Randomized Study

    Sponsor: Fundacion Dexeus. Phase: NA. Conditions: Infertility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04799301: Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE1. Conditions: Diet Therapy, Healthy Volunteers

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07541001: PRL3-Zumab in Patients With Advanced Solid Tumors

    Sponsor: Intra-IMMUSG Pte Ltd. Phase: PHASE2. Conditions: Advanced Malignant Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07606001: Yellow Potatoes and Carotenoids

    Sponsor: University of Florida. Phase: NA. Conditions: Carotenoids

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04431479: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

    Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06871579: Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Helicobacter Pylori

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07530588: Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

    Sponsor: University Hospital of North Norway. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04838288: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Renal Transplant

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07474688: Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure

    Sponsor: China-Japan Friendship Hospital. Phase: . Conditions: Uterine Fibroids (Leiomyoma)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06282588: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

    Sponsor: Cancer Research Antwerp. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01969227: The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

    Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE2. Conditions: Chronic Graft Versus Host Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06545461: Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

    Sponsor: Donald Wesson. Phase: NA. Conditions: Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06037161: Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums

    Sponsor: Case Western Reserve University. Phase: NA. Conditions: Recession, Gingival

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506486: Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study)

    Sponsor: Universitas Padjadjaran. Phase: NA. Conditions: Stroke (Subacute)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07336186: The Effect of Virtual Reality-Based Relaxation on Breast Milk Volume and Breastfeeding Self-Efficacy in Mothers of Preterm Infants

    Sponsor: Kocaeli University. Phase: NA. Conditions: Lactation, Breastfeeding, Premature Birth, Maternal Stress, Self-Efficacy

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05089786: Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)

    Sponsor: InSightec. Phase: NA. Conditions: Essential Tremor, Neurology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07634770: Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

    Sponsor: Sam Chun Dang Pharm. Co. Ltd.. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07610473: A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

    Sponsor: Draig Therapeutics Ltd. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07619469: Motion Sickness Severity and Sensorimotor Performance

    Sponsor: Istinye University. Phase: . Conditions: Motion Sickness, Somatosensory Disorders, Dizziness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06054269: Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

    Sponsor: Centers for Disease Control and Prevention. Phase: PHASE3. Conditions: Influenza

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07121283: Artificial Intelligence Assisted Bone Age Assessment

    Sponsor: Cheng-Hsin General Hospital. Phase: NA. Conditions: Bone Age

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02530983: Mayo Clinic Upper Digestive Disease Survey

    Sponsor: Mayo Clinic. Phase: . Conditions: Esophageal Neoplasms, Cancer of Esophagus, Cancer of the Esophagus, Esophageal Cancer, Esophagus Cancer, Neoplasm, Esophageal, Esophagectomy, Abnormalities, Digestive System, Digestive System Abnormalities

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04002141: Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

    Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Endometriosis, Ovarian Hyperstimulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06334354: A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06105541: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder, Ehlers-Danlos Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06940141: Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

    Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07435441: Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke

    Sponsor: Istanbul Arel University. Phase: . Conditions: Post-stroke, Dysphagia, Videofluoroscopy, Scale Reliability Validity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997094: Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

    Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma, Resectable Head and Neck Squamous-cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06665594: Effect of TXA on Reducing Bruising After Filler Injection

    Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05687266: Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: NSCLC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05558566: Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

    Sponsor: Yale University. Phase: NA. Conditions: Tourette Syndrome in Adolescence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01625351: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE1. Conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma

    full page →ctgov ↗
    ← prev
    page 70 of 104
    next →